Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation Study.

Khot A, Brajanovski N, Cameron DP, Hein N, Maclachlan KH, Sanij E, Lim J, Soong J, Link E, Blombery P, Thompson ER, Fellowes A, Sheppard KE, McArthur GA, Pearson RB, Hannan RD, Poortinga G, Harrison SJ.

Cancer Discov. 2019 Aug;9(8):1036-1049. doi: 10.1158/2159-8290.CD-18-1455. Epub 2019 May 15.

PMID:
31092402
2.

Weight-Based Enoxaparin for Venous Thromboembolism in Obesity Gives Similar Anti-Xa Levels to Patients <100 kg, with No Increase in Major Bleeding.

Maclachlan KH, Stevens HP, Tran HA, Chunilal SD.

Semin Thromb Hemost. 2019 Feb;45(1):94-99. doi: 10.1055/s-0038-1677019. Epub 2019 Jan 10.

PMID:
30630208

Supplemental Content

Loading ...
Support Center